Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1021 to 1035 of 1108 results for infections

  1. The SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of the biliary system (MIB21)

    NICE has developed a Medtech Innovation Briefing (MIB) on the SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of

    Medtech innovation briefing
    Published
    12 February 2015

  2. Rehabilitation after traumatic injury (NG211)

    This guideline covers complex rehabilitation needs after traumatic injury, including assessment and goal setting, rehabilitation plans and programmes, physical, psychological and cognitive rehabilitation, rehabilitation for specific injuries, coordination of rehabilitation in hospital, at discharge and in the community, and commissioning and organising rehabilitation services.

    NICE guideline
    Published
    18 January 2022
    View recommendations

    Sections for NG211

  3. Leukomed Sorbact for preventing surgical site infection (MTG55)

    We have moved Medical technologies guidance 55 to become HealthTech guidance 567. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  4. Plus Sutures for preventing surgical site infection (MTG59)

    We have moved Medical technologies guidance 59 to become HealthTech guidance 586. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  5. Leukomed Sorbact for preventing surgical site infection (MIB197)

    This advice has been updated and replaced by NICE healthtech guidance 567.

    Withdrawn advice

  6. Plus Sutures for preventing surgical site infection (MIB204)

    This advice has been updated and replaced by NICE healthtech guidance guidance 586.

    Withdrawn advice

  7. Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A in people 2 years and over (TA1051)

    Evidence-based recommendations on efanesoctocog alfa (Altuvoct) for treating and preventing bleeding episodes in haemophilia A in people 2 years and over.

    Technology appraisal guidance
    Published
    2 April 2025
    View recommendations

    Sections for TA1051

  8. Sotatercept for treating pulmonary arterial hypertension (TA1161)

    Evidence-based recommendations on sotatercept (Winrevair) for pulmonary arterial hypertension in adults.

    Technology appraisal guidance
    Published
    3 June 2026
    View recommendations

    Sections for TA1161

  9. Symptoms and signs of recurrent UTI:  Do the symptoms and signs of UTI in babies, children and young people aged under 16 years differ in those with a history of recurrent UTIs compared with those without a history of recurrent UTI?

    Source guidance details Comes from guidance Urinary tract infection in under 16s: diagnosis and management Number NG224 Date

    Research recommendation
    Published
    4 August 2022

  10. Symptoms and signs of long-term (chronic) UTI: What symptoms and signs do children and young people with long-term (chronic) UTI report and what do they perceive is the impact on their health and quality of life?

    Source guidance details Comes from guidance Urinary tract infection in under 16s: diagnosis and management Number NG224 Date

    Research recommendation
    Published
    4 August 2022

  11. Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM65)

    Summary of the evidence on high-strength insulin glargine 300 units/ml (Toujeo) for type 2 diabetes mellitus to inform local NHS planning and decision-making

    Evidence summary
    Published
    2 December 2015

  12. Urinary tract infection in under 16s: diagnosis and management (CG54)

    This guidance has been updated and replaced by NICE guideline NG224.

    Withdrawn guideline

  13. Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours (TA265)

    Evidence-based recommendations on denosumab (XGEVA) for the prevention of skeletal-related events in adults with bone metastases from solid tumours.

    Technology appraisal guidance
    Published
    24 October 2012
    View recommendations

    Sections for TA265

  14. Video laryngoscopes to help intubation in people with difficult airways (MIB167)

    NICE has developed a medtech innovation briefing (MIB) on video laryngoscopy to help intubation in people with difficult airways .

    Medtech innovation briefing
    Published
    19 December 2018

  15. Urinary incontinence in women (QS77)

    This quality standard covers managing urinary incontinence in women (aged 18 and over). It covers assessment, care and treatment options. It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    9 December 2021
    View quality statements

    Sections for QS77